Last reviewed · How we verify
NCT05516173: TUN-BP-BLUE
Role of Depression in Blood Pressure Control. Study
trial testing Blood Pressure Monitoring, Ambulatory in Hypertension in 302 participants. Status unknown.
15 November 2022
Quick facts
| Lead sponsor | General Administration of Military Health, Tunisia |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 302 |
| Start date | 15 August 2022 |
| Primary completion | 15 November 2022 |
| Estimated completion | 15 January 2023 |
| Sites | 4 locations across Tunisia |
Drugs / interventions tested
- Blood Pressure Monitoring, Ambulatory
Conditions studied
- Hypertension — all drugs for Hypertension →
- Depression — all drugs for Depression →
Sponsor
General Administration of Military Health, Tunisia — full company profile →
Who can join
Adults 18 to 100, any sex, with Hypertension or Depression. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Our study aims to evaluate the role of depression in blood pressure control in ambulatory hypertensive patients.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Role of depression in blood pressure control. A cross-sectional multicentric study.
Raddaoui Y, Ben Amara A, Noamen A, Antit S, et al · · 2024 · cited 1× · PMID 38545723 · DOI 10.62438/tunismed.v102i1.4723
Verify or expand the search:
- PubMed search for NCT05516173
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hypertension
Currently open trials in the same condition.
- NCT07413159 — The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans A · NA · recruiting
- NCT07361276 — Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care S · recruiting
- NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
- NCT07238400 — Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia · Phase 2 · recruiting
- NCT07135505 — Early Time-Restricted Eating in Older Adults With Hypertension · NA · recruiting
Other General Administration of Military Health, Tunisia trials
Trials by the same sponsor.
- NCT06283329 — Residual Vocal Cords Curarization Correlation Between Clinical and Ultrasound Endpoints · completed
- NCT05993312 — Quality of Life in Traumatic Brain Injury Patients · unknown
- NCT06021912 — e-ITAG Allergen Immunotherapy in the Management of Allergic Asthma · unknown
- NCT05311111 — Efficacy and Safety of the Distal Radial Approach · NA · unknown
- NCT05822180 — Evaluation of the Efficacy and Safety of Nano-S1 · Phase 3 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05516173 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by General Administration of Military Health, Tunisia
- Last refreshed: 26 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05516173.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing